Cyclophosphamide/Fludarabine/Rituximab and Hyaluronidase Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of fludarabine, cyclophosphamide and a fixed combination of rituximab and human hyaluronidase that can be used for the treatment of chronic lymphocytic leukemia (CLL).

**Synonyms:** - Cyclophosphamide-Fludarabine-Rituxan Hycela Regimen - Cyclophosphamide-Fludarabine-Rituximab and Human Hyaluronidase - Cyclophosphamide-Fludarabine-Rituximab and Hyaluronidase - Cyclophosphamide/Fludarabine/ Rituxan Hycela - Cyclophosphamide/Fludarabine/Rituximab and Hyaluronidase - Cyclophosphamide/Fludarabine/Rituximab and Hyaluronidase Human - FC- Rituxan Hycela - FCR (Rituxan Hycela) - FCR (Rituximab and Hyaluronidase) - FCR (Rituximab and hyaluronidase) - Rituxan Hycela-FC